A carregar...

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma

In advanced-stage hepatocellular carcinoma (HCC), systemic treatment represents the standard therapy. Target therapy has marked a new era based on a greater knowledge of molecular disease signaling. Nonetheless, survival outcomes and long-term response remain unsatisfactory, mostly because of the on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Michela Guardascione, Giuseppe Toffoli
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-08-01
Colecção:International Journal of Molecular Sciences
Assuntos:
Acesso em linha:https://www.mdpi.com/1422-0067/21/17/6302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!